International ME/CFS Conference 2026

Videos presentations

+++ First videos of talks from 2026 now online. More will be added gradually throughout June. +++        

Charité – Universitätsmedizin Berlin and ME/CFS Research Foundation organised the International ME/CFS Conference 2026 on 7-8 May in Berlin. The event was directed at medical professionals, researchers and interdisciplinary experts in the fields of medicine and biology.


In addition to presentations, the two-day hybrid Conference featured a wide range of scientific posters. Among the submitted posters, outstanding contributions were awarded poster prizes by the ME/CFS Research Foundation via a scientific jury.

Presentations were held in English. The second day of the Conference featured an afternoon Symposium for a German speaking audience. Videos, presentations and short summaries of the lectures will be added gradually on this website.

Welcome

Welcome

Welcome

Carmen Scheibenbogen
Charité – Universitätsmedizin Berlin, Germany
Welcome

Welcome

Jörg Heydecke
ME/CFS Research Foundation, Germany

Key breakthroughs I: Genetics and markers of autoimmunity

DecodeME genetics

DecodeME genetics

Chris Ponting
University of Edinburgh, UK
Markers of Autoimmunity in ME/CFS and PCS

Markers of Autoimmunity in ME/CFS and PCS

Birgit Sawitzki
Charité – Universitätsmedizin Berlin, Germany

Key breakthroughs II: Neuroimaging

Whole body PET/MR imaging in ME/CFS

Whole body PET/MR imaging in ME/CFS

Michelle James
Stanford University, USA
White Matter Neuroinflammation in ME/CFS

White Matter Neuroinflammation in ME/CFS

Qiang Yu
University of the Sunshine Coast, Australia
Neuroimaging Findings in ME/CFS and PCS

Neuroimaging Findings in ME/CFS and PCS

Carsten Finke
Charité – Universitätsmedizin Berlin, Germany

Selected poster presentations

Symptom Profile in Post-COVID-19 Condition

Symptom Profile in Post-COVID-19 Condition

Elsa Biteus
Karolinska Institute, Sweden
Reduced inflammatory potential of HDL

Reduced inflammatory potential of HDL

Elisabeth Schieffer
University Hospital of Giessen and Marburg (UKGM), Marburg, Germany
Perfusion Across Scales in ME/CFS

Perfusion Across Scales in ME/CFS

Annabell Sprenger
University Hospital Regensburg, Germany
Exhaustion of NK Cells in PCS

Exhaustion of NK Cells in PCS

Isabelle Lethen
Technical University of Munich (TUM) Hospital, Germany
Sex differences in metabolites

Sex differences in metabolites

Cornelia Pipper-Krampl
FH JOANNEUM, Austria

Understanding I: Vascular dysregulation

Endothelial Dysfunction and Hypoperfusion

Endothelial Dysfunction and Hypoperfusion

Martina Seifert
Charité – Universitätsmedizin Berlin, Germany
Signals in the Flow

Signals in the Flow

Alain Moreau
University of Montreal, Canada
MYOFLAME-19

MYOFLAME-19

Valentina Puntmann
Goethe University Frankfurt, Germany

Understanding II: Neuronal dysregulation

Metabolic and immune system change in ME/CFS

Metabolic and immune system change in ME/CFS

Helena Radbruch
Charité – Universitätsmedizin Berlin, Germany
Reduced ATP-to-phosphocreatine Ratios in PCS

Reduced ATP-to-phosphocreatine Ratios in PCS

Gabriele Ende
Central Institute of Mental Health (CIMH) Mannheim, Germany
Mechanisms of Sleep Disturbance in ME/CFS
Available soon

Mechanisms of Sleep Disturbance in ME/CFS

Claudia Schilling
Central Institute of Mental Health (CIMH) Mannheim, Germany

Understanding III: Immune and metabolic dysregulation

Effects of Autoantibodies on Neuronal Function
Available soon

Effects of Autoantibodies on Neuronal Function

Marlen Alisch
Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and Charité – Universitätsmedizin Berlin, Germany
Beyond the Trigger
Available soon

Beyond the Trigger

Nina Babel
Ruhr University Bochum, Germany
Bio-SIG PEM study
Available soon

Bio-SIG PEM study

Christian Puta
Friedrich Schiller University Jena, Germany
Lipidomics and Metabolomics in ME/CFS
Available soon

Lipidomics and Metabolomics in ME/CFS

Christopher Armstrong
University of Melbourne, Australia

Treatment I: Care and novel trials

PEDNET-LC (English)
Available soon

PEDNET-LC (English)

Uta Behrends
TUM University Hospital, Technical University Munich, Germany
CFS_CARE
Available soon

CFS_CARE

Kirsten Wittke
Charité – Universitätsmedizin Berlin, Germany
Efficacy of HBOT in ME/CFS
Available soon

Efficacy of HBOT in ME/CFS

Claudia Kedor
Charité – Universitätsmedizin Berlin, Germany
Low Dose Naltrexone in Post-Covid
Available soon

Low Dose Naltrexone in Post-Covid

Luis Nacul
University of British Columbia, Canada
Cohen Center for Recovery from complex Chronic Illness: Research Updates
Available soon

Cohen Center for Recovery from complex Chronic Illness: Research Updates

David Putrino
Icahn School of Medicine at Mount Sinai, New York, USA
Methylprednisolone in PCS
Available soon

Methylprednisolone in PCS

Lucas Adam
Charité – Universitätsmedizin Berlin, Germany

Treatment II: Clinical trials targeting immune dysregulation

Low Dose Rapamycin in ME/CFS
Available soon

Low Dose Rapamycin in ME/CFS

Gunnar Gottschalk
Simmaron Research, USA
Daratumumab in ME/CFS
Available soon

Daratumumab in ME/CFS

Øystein Fluge
University of Bergen, Norway
Immunoadsorption in ME/CFS and PCS
Available soon

Immunoadsorption in ME/CFS and PCS

Elisa Stein
Charité – Universitätsmedizin Berlin, Germany
IA-PACS-CFS
Available soon

IA-PACS-CFS

Hannah Pressler
Charité – Universitätsmedizin Berlin, Germany
CD19 B Cell Depletion in ME/CFS
Available soon

CD19 B Cell Depletion in ME/CFS

Judith Bellmann-Strobl
Charité – Universitätsmedizin Berlin, Germany

ME/CFS Symposium 2026 – Versorgung und Therapie in Deutschland

Grußworte

Grußworte

Nina Warken
Federal Ministry of Health (BMG), Germany
Grußworte

Grußworte

Dorothee Bär
Federal Ministry of Research, Technology and Space (BMFTR), Germany
Nationale Dekade gegen Postinfektiöse Erkrankungen

Nationale Dekade gegen Postinfektiöse Erkrankungen

Natascha Sommer
University Hospital of Giessen and Marburg (UKGM), Giessen, Germany

Versorgung: Modellvorhaben zu ME/CFS und Post-COVID-Syndrom (PCS)

PEDNET-LC (Deutsch)

PEDNET-LC (Deutsch)

Uta Behrends
TUM University Hospital, Technical University Munich, Germany
ACCESS

ACCESS

Meike Dirks
Hannover Medical School (MHH), Germany
Pais Care Berlin

Pais Care Berlin

Kirsten Wittke
Charité – Universitätsmedizin Berlin, Germany
Psychotherapie und ME/CFS

Psychotherapie und ME/CFS

Bettina Grande
Charité – Universitätsmedizin Berlin, Germany
UNCOVER

UNCOVER

Georg Schomerus
University Clinic Leipzig, Germany

Therapie: Neue Ergebnisse zu ME/CFS und PCS

Praxisleitfaden und Off-Label-Therapie bei ME/CFS

Praxisleitfaden und Off-Label-Therapie bei ME/CFS

Marie Witt
German Association for ME/CFS, Germany
Immunadsorption bei ME/CFS und Post-COVID-ME/CFS

Immunadsorption bei ME/CFS und Post-COVID-ME/CFS

Elisa Stein
Charité – Universitätsmedizin Berlin, Germany
B-/Plasmazell-Depletion bei ME/CFS

B-/Plasmazell-Depletion bei ME/CFS

Judith Bellmann-Strobl
Charité – Universitätsmedizin Berlin, Germany
Wirksamkeit der Hyperbaren Sauerstofftherapie bei ME/CFS

Wirksamkeit der Hyperbaren Sauerstofftherapie bei ME/CFS

Claudia Kedor
Charité – Universitätsmedizin Berlin, Germany
Therapiestudien zu ME/CFS und PCS

Therapiestudien zu ME/CFS und PCS

Carmen Scheibenbogen
Charité – Universitätsmedizin Berlin, Germany

Sponsors of the International ME/CFS Conference

The following sponsors are supporting the International ME/CFS Conference 2026. The ME/CFS Symposium 2026 (in German) on 8 May is not funded by these organisations. Weidenhammer Zoebele Stiftung and Lost Voices Stiftung provide overall support to Charité Fatigue Center.

Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo